保持比率受损的螺旋测量和非吸烟者的喘死亡率:一个基于人口的队列研究
Xiu Shi1, Qingqing Li1, Zhenhong Hu2
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
概括
保留比率受损螺旋计 (PRISm) 在非吸烟喘患者中显著增加死亡风险. 这一发现突出了PRISm作为喘患者结果的关键因素.
科学领域:
- 肺部病理学 肺部病理学
- 流行病学 流行病学
- 临床医学 临床医学
背景情况:
- 保持比率受损螺旋计 (PRISm) 是一种与喘相关的疾病.
- 在非吸烟喘患者中,PRISm与死亡风险之间的关联尚不清楚.
- 研究PRISM对死亡率的影响对于喘管理至关重要.
研究的目的:
- 为了确定PRISm是否会增加成人喘患者的全因死亡风险,而在基线时没有吸烟史或空气流阻塞.
- 为了比较使用PRISm的喘患者和使用正常螺旋计的喘患者之间的死亡率.
主要方法:
- 对748名没有吸烟史的成人喘患者进行前性队列研究.
- 参与者被分类为正常的螺旋计 (预测FEV1 ≥80%) 或PRISM (预测FEV1 <80%).
- 随访时间中位数为9.6年;使用多变量考克斯回归和卡普兰-梅尔生存分析进行分析.
主要成果:
- 在基线时,PRISm在8.52%的参与者中存在.
- PRISm独立地与所有原因死亡风险增加6.57倍相关 (aHR=6.57,95%CI:2.33-18.47,p <0.001).
- 卡普兰-梅尔分析显示,PRISm组的生存率明显较差 (日志排名p = 0.006).
结论:
- 在没有基线气流阻塞的非吸烟喘患者中,PRISm与全因死亡率的增加显著相关.
- 在敏感性分析中,这种关联仍然显著,证实了强度.
- 研究结果表明,PRISM是喘的关键预后指标,尽管广泛的置信区间需要谨慎解释.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Pulmonary Function Tests
436
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
436
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K


